Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × lirilumab × Clear all

Phase

Status

Completed 6 Terminated 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 514 Specimen Handling 423 Carboplatin 387 Magnetic Resonance Spectroscopy 379 Cisplatin 361 Cyclophosphamide 344 Radiotherapy 316 Gemcitabine 270 Bevacizumab 266 Paclitaxel 255 Biopsy 247 Drug Therapy 241 Blood Specimen Collection 217 venetoclax 202 fludarabine 200 Nivolumab 200 Capecitabine 195 Oxaliplatin 190 Docetaxel 185 Injections 179 Fluorouracil 169 Dexamethasone 159 Radiosurgery 157 Pemetrexed 140 Rituximab 138 Standard of Care 134 Surgical Procedures, Operative 132 durvalumab 128 atezolizumab 124 tislelizumab 120

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡